LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Linde, Lauren"
  2. AU="Brewer, Katlyn K"
  3. AU="Prow, Natalie A"
  4. AU=Venkatesan Arun
  5. AU="Russcher, H."
  6. AU="Chambino, Beatriz"
  7. AU="L'Abbé, Ericka N."
  8. AU=Moore Stephen M.
  9. AU="Gabriel, Berteșteanu Șerban Vifor" AU="Gabriel, Berteșteanu Șerban Vifor"
  10. AU="Gallo, Eduado"
  11. AU="Yurchenko, Maria"
  12. AU="Fabiana Giber"
  13. AU="Rajakumar, Gopal Suseela" AU="Rajakumar, Gopal Suseela"
  14. AU="Gutierrez, M. N"
  15. AU=Zhuo Jia L.
  16. AU=Miller Mark A
  17. AU="Dąbrowski, Leszek"
  18. AU="Röltgen, Katharina"
  19. AU="Tumanov, Alexey"
  20. AU="Berns, Lauren"
  21. AU="Elena A. Deshevaya"
  22. AU=Zhang Ruijuan
  23. AU="Mueller, Luke"
  24. AU=Barzon Luisa
  25. AU="Karunakaran, Denuja"
  26. AU="Figueroa-Rivera, Ivonne M"
  27. AU="Blackburn, Fran"
  28. AU="Lee, Hee-Kyung"
  29. AU=Kinoshita J H
  30. AU="Hernesniemi, Juha"
  31. AU="Evans, Matthew L"
  32. AU=Payne Thomas
  33. AU="Brown, Dexter"

Suchergebnis

Treffer 1 - 7 von insgesamt 7

Suchoptionen

  1. Artikel ; Online: Beyond Diagnosis: Xpert Cycle Threshold Values as Predictors of Tuberculosis Transmission.

    Linde, Lauren / Brooks, Meredith B / Martinez, Leonardo

    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

    2024  

    Sprache Englisch
    Erscheinungsdatum 2024-01-03
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 1099781-7
    ISSN 1537-6591 ; 1058-4838
    ISSN (online) 1537-6591
    ISSN 1058-4838
    DOI 10.1093/cid/ciad791
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Tuberculosis Diagnoses Following Wildfire Smoke Exposure in California.

    Linde, Lauren R / Readhead, Adam / Barry, Pennan M / Balmes, John R / Lewnard, Joseph A

    American journal of respiratory and critical care medicine

    2022  Band 207, Heft 3, Seite(n) 336–345

    Abstract: Rationale: ...

    Abstract Rationale:
    Mesh-Begriff(e) Humans ; United States ; Aged ; Wildfires ; Particulate Matter/adverse effects ; Particulate Matter/analysis ; Smoke/adverse effects ; Air Pollution ; California/epidemiology ; Tuberculosis/diagnosis ; Tuberculosis/epidemiology ; Air Pollutants/adverse effects ; Air Pollutants/analysis ; Environmental Exposure/adverse effects
    Chemische Substanzen Particulate Matter ; Smoke ; Air Pollutants
    Sprache Englisch
    Erscheinungsdatum 2022-09-14
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.202203-0457OC
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Logically Inferred Tuberculosis Transmission (LITT): A Data Integration Algorithm to Rank Potential Source Cases.

    Winglee, Kathryn / McDaniel, Clinton J / Linde, Lauren / Kammerer, Steve / Cilnis, Martin / Raz, Kala M / Noboa, Wendy / Knorr, Jillian / Cowan, Lauren / Reynolds, Sue / Posey, James / Sullivan Meissner, Jeanne / Poonja, Shameer / Shaw, Tambi / Talarico, Sarah / Silk, Benjamin J

    Frontiers in public health

    2021  Band 9, Seite(n) 667337

    Abstract: Understanding tuberculosis (TB) transmission chains can help public health staff target their resources to prevent further transmission, but currently there are few tools to automate this process. We have developed the Logically Inferred Tuberculosis ... ...

    Abstract Understanding tuberculosis (TB) transmission chains can help public health staff target their resources to prevent further transmission, but currently there are few tools to automate this process. We have developed the Logically Inferred Tuberculosis Transmission (LITT) algorithm to systematize the integration and analysis of whole-genome sequencing, clinical, and epidemiological data. Based on the work typically performed by hand during a cluster investigation, LITT identifies and ranks potential source cases for each case in a TB cluster. We evaluated LITT using a diverse dataset of 534 cases in 56 clusters (size range: 2-69 cases), which were investigated locally in three different U.S. jurisdictions. Investigators and LITT agreed on the most likely source case for 145 (80%) of 181 cases. By reviewing discrepancies, we found that many of the remaining differences resulted from errors in the dataset used for the LITT algorithm. In addition, we developed a graphical user interface, user's manual, and training resources to improve LITT accessibility for frontline staff. While LITT cannot replace thorough field investigation, the algorithm can help investigators systematically analyze and interpret complex data over the course of a TB cluster investigation.
    Mesh-Begriff(e) Algorithms ; Humans ; Molecular Epidemiology ; Mycobacterium tuberculosis/genetics ; Tuberculosis/epidemiology ; Whole Genome Sequencing
    Sprache Englisch
    Erscheinungsdatum 2021-06-21
    Erscheinungsland Switzerland
    Dokumenttyp Journal Article ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 2711781-9
    ISSN 2296-2565 ; 2296-2565
    ISSN (online) 2296-2565
    ISSN 2296-2565
    DOI 10.3389/fpubh.2021.667337
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: Application of a life table approach to assess duration of BNT162b2 vaccine-derived immunity by age using COVID-19 case surveillance data during the Omicron variant period.

    Sternberg, Maya R / Johnson, Amelia / King, Justice / Ali, Akilah R / Linde, Lauren / Awofeso, Abiola O / Baker, Jodee S / Bayoumi, Nagla S / Broadway, Steven / Busen, Katherine / Chang, Carolyn / Cheng, Iris / Cima, Mike / Collingwood, Abi / Dorabawila, Vajeera / Drenzek, Cherie / Fleischauer, Aaron / Gent, Ashley / Hartley, Amanda /
    Hicks, Liam / Hoskins, Mikhail / Jara, Amanda / Jones, Amanda / Khan, Saadiah I / Kamal-Ahmed, Ishrat / Kangas, Sarah / Kanishka, Fnu / Kleppinger, Alison / Kocharian, Anna / León, Tomás M / Link-Gelles, Ruth / Lyons, B Casey / Masarik, John / May, Andrea / McCormick, Donald / Meyer, Stephanie / Milroy, Lauren / Morris, Keeley J / Nelson, Lauren / Omoike, Enaholo / Patel, Komal / Pietrowski, Michael / Pike, Melissa A / Pilishvili, Tamara / Peterson Pompa, Xandy / Powell, Charles / Praetorius, Kevin / Rosenberg, Eli / Schiller, Adam / Smith-Coronado, Mayra L / Stanislawski, Emma / Strand, Kyle / Tilakaratne, Buddhi P / Vest, Hailey / Wiedeman, Caleb / Zaldivar, Allison / Silk, Benjamin / Scobie, Heather M

    PloS one

    2023  Band 18, Heft 9, Seite(n) e0291678

    Abstract: Background: SARS-CoV-2 Omicron variants have the potential to impact vaccine effectiveness and duration of vaccine-derived immunity. We analyzed U.S. multi-jurisdictional COVID-19 vaccine breakthrough surveillance data to examine potential waning of ... ...

    Abstract Background: SARS-CoV-2 Omicron variants have the potential to impact vaccine effectiveness and duration of vaccine-derived immunity. We analyzed U.S. multi-jurisdictional COVID-19 vaccine breakthrough surveillance data to examine potential waning of protection against SARS-CoV-2 infection for the Pfizer-BioNTech (BNT162b) primary vaccination series by age.
    Methods: Weekly numbers of SARS-CoV-2 infections during January 16, 2022-May 28, 2022 were analyzed by age group from 22 U.S. jurisdictions that routinely linked COVID-19 case surveillance and immunization data. A life table approach incorporating line-listed and aggregated COVID-19 case datasets with vaccine administration and U.S. Census data was used to estimate hazard rates of SARS-CoV-2 infections, hazard rate ratios (HRR) and percent reductions in hazard rate comparing unvaccinated people to people vaccinated with a Pfizer-BioNTech primary series only, by age group and time since vaccination.
    Results: The percent reduction in hazard rates for persons 2 weeks after vaccination with a Pfizer-BioNTech primary series compared with unvaccinated persons was lowest among children aged 5-11 years at 35.5% (95% CI: 33.3%, 37.6%) compared to the older age groups, which ranged from 68.7%-89.6%. By 19 weeks after vaccination, all age groups showed decreases in the percent reduction in the hazard rates compared with unvaccinated people; with the largest declines observed among those aged 5-11 and 12-17 years and more modest declines observed among those 18 years and older.
    Conclusions: The decline in vaccine protection against SARS-CoV-2 infection observed in this study is consistent with other studies and demonstrates that national case surveillance data were useful for assessing early signals in age-specific waning of vaccine protection during the initial period of SARS-CoV-2 Omicron variant predominance. The potential for waning immunity during the Omicron period emphasizes the importance of continued monitoring and consideration of optimal timing and provision of booster doses in the future.
    Mesh-Begriff(e) Child ; Humans ; Aged ; BNT162 Vaccine ; COVID-19 Vaccines ; COVID-19/epidemiology ; COVID-19/prevention & control ; Life Tables ; SARS-CoV-2 ; Vaccines
    Chemische Substanzen BNT162 Vaccine ; COVID-19 Vaccines ; Vaccines
    Sprache Englisch
    Erscheinungsdatum 2023-09-20
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2267670-3
    ISSN 1932-6203 ; 1932-6203
    ISSN (online) 1932-6203
    ISSN 1932-6203
    DOI 10.1371/journal.pone.0291678
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Notes from the Field: Comparison of COVID-19 Mortality Rates Among Adults Aged ≥65 Years Who Were Unvaccinated and Those Who Received a Bivalent Booster Dose Within the Preceding 6 Months - 20 U.S. Jurisdictions, September 18, 2022-April 1, 2023.

    Johnson, Amelia G / Linde, Lauren / Payne, Amanda B / Ali, Akilah R / Aden, Vanessa / Armstrong, Brandy / Armstrong, Brett / Auche, Steven / Bayoumi, Nagla S / Bennett, Sarah / Boulton, Rachelle / Chang, Carolyn / Collingwood, Abigail / Cueto, Kevin / Davidson, Sherri L / Du, Yi / Fleischauer, Aaron / Force, Victoria / Frank, Darren /
    Hamilton, Ross / Harame, Kaitlin / Harrington, Pauline / Hicks, Liam / Hodis, Jeffrey D / Hoskins, Mikhail / Jones, Amanda / Kanishka, Fnu / Kaur, Ramandeep / Kirkendall, Samantha / Khan, Saadiah I / Klioueva, Anna / Link-Gelles, Ruth / Lyons, Shelby / Mansfield, Joshua / Markelz, Amanda / Masarik, John / Mendoza, Erica / Morris, Keeley / Omoike, Enaholo / Paritala, Sai / Patel, Komal / Pike, Melissa / Pompa, Xandy Peterson / Praetorius, Kevin / Rammouni, Nadine / Razzaghi, Hilda / Riggs, Alexa / Shi, Minchan / Sigalo, Nekabari / Stanislawski, Emma / Tilakaratne, Buddhi P / Turner, Kathryn A / Wiedeman, Caleb / Silk, Benjamin J / Scobie, Heather M

    MMWR. Morbidity and mortality weekly report

    2023  Band 72, Heft 24, Seite(n) 667–669

    Mesh-Begriff(e) Aged ; Humans ; COVID-19/mortality ; COVID-19/prevention & control ; COVID-19 Vaccines/administration & dosage ; Vaccines, Combined
    Chemische Substanzen COVID-19 Vaccines ; Vaccines, Combined
    Sprache Englisch
    Erscheinungsdatum 2023-06-16
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 412775-4
    ISSN 1545-861X ; 0149-2195
    ISSN (online) 1545-861X
    ISSN 0149-2195
    DOI 10.15585/mmwr.mm7224a6
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  6. Artikel ; Online: COVID-19 Incidence and Mortality Among Unvaccinated and Vaccinated Persons Aged ≥12 Years by Receipt of Bivalent Booster Doses and Time Since Vaccination - 24 U.S. Jurisdictions, October 3, 2021-December 24, 2022.

    Johnson, Amelia G / Linde, Lauren / Ali, Akilah R / DeSantis, Allison / Shi, Minchan / Adam, Carolyn / Armstrong, Brandy / Armstrong, Brett / Asbell, Madison / Auche, Steven / Bayoumi, Nagla S / Bingay, Boudu / Chasse, Melisse / Christofferson, Scott / Cima, Michael / Cueto, Kevin / Cunningham, Spencer / Delgadillo, Janelle / Dorabawila, Vajeera /
    Drenzek, Cherie / Dupervil, Brandi / Durant, Tonji / Fleischauer, Aaron / Hamilton, Ross / Harrington, Pauline / Hicks, Liam / Hodis, Jeffrey D / Hoefer, Dina / Horrocks, Sam / Hoskins, Mikhail / Husain, Sofia / Ingram, L Amanda / Jara, Amanda / Jones, Amanda / Kanishka, F N U / Kaur, Ramandeep / Khan, Saadiah I / Kirkendall, Samantha / Lauro, Priscilla / Lyons, Shelby / Mansfield, Joshua / Markelz, Amanda / Masarik, John / McCormick, Donald / Mendoza, Erica / Morris, Keeley J / Omoike, Enaholo / Patel, Komal / Pike, Melissa A / Pilishvili, Tamara / Praetorius, Kevin / Reed, Isaiah G / Severson, Rachel L / Sigalo, Nekabari / Stanislawski, Emma / Stich, Sarah / Tilakaratne, Buddhi P / Turner, Kathryn A / Wiedeman, Caleb / Zaldivar, Allison / Silk, Benjamin J / Scobie, Heather M

    MMWR. Morbidity and mortality weekly report

    2023  Band 72, Heft 6, Seite(n) 145–152

    Abstract: On September 1, 2022, CDC recommended an updated (bivalent) COVID-19 vaccine booster to help restore waning protection conferred by previous vaccination and broaden protection against emerging variants for persons aged ≥12 years (subsequently extended to ...

    Abstract On September 1, 2022, CDC recommended an updated (bivalent) COVID-19 vaccine booster to help restore waning protection conferred by previous vaccination and broaden protection against emerging variants for persons aged ≥12 years (subsequently extended to persons aged ≥6 months).* To assess the impact of original (monovalent) COVID-19 vaccines and bivalent boosters, case and mortality rate ratios (RRs) were estimated comparing unvaccinated and vaccinated persons aged ≥12 years by overall receipt of and by time since booster vaccination (monovalent or bivalent) during Delta variant and Omicron sublineage (BA.1, BA.2, early BA.4/BA.5, and late BA.4/BA.5) predominance.
    Mesh-Begriff(e) Humans ; Aged ; COVID-19 Vaccines ; COVID-19/epidemiology ; COVID-19/prevention & control ; Incidence ; SARS-CoV-2 ; Vaccination
    Chemische Substanzen COVID-19 Vaccines
    Sprache Englisch
    Erscheinungsdatum 2023-02-10
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 412775-4
    ISSN 1545-861X ; 0149-2195
    ISSN (online) 1545-861X
    ISSN 0149-2195
    DOI 10.15585/mmwr.mm7206a3
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  7. Artikel ; Online: Severe Acute Respiratory Syndrome Coronavirus 2 and Respiratory Virus Sentinel Surveillance, California, USA, May 10, 2020-June 12, 2021.

    Cooksey, Gail L Sondermeyer / Morales, Christina / Linde, Lauren / Schildhauer, Samuel / Guevara, Hugo / Chan, Elena / Gibb, Kathryn / Wong, Jessie / Lin, Wen / Bonin, Brandon J / Arizmendi, Olivia / Lam-Hine, Tracy / Tzvieli, Ori / McDowell, Ann / Kampen, Kirstie M / Lopez, Denise L / Ennis, Josh / Lewis, Linda S / Oren, Eyal /
    Hatada, April / Molinar, Blanca / Frederick, Matt / Han, George S / Sanchez, Martha / Garcia, Michael A / McGrath, Alana / Le, Nga Q / Boyd, Eric / Bertolucci, Regina M / Corrigan, Jeremy / Brodine, Stephanie / Austin, Michael / Roach, William R K / Levin, Robert M / Tyson, Brian M / Pry, Jake M / Cummings, Kristin J / Wadford, Debra A / Jain, Seema

    Emerging infectious diseases

    2021  Band 28, Heft 1, Seite(n) 9–19

    Abstract: State and local health departments established the California Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Respiratory Virus Sentinel Surveillance System to conduct enhanced surveillance for SARS-CoV-2 and other respiratory pathogens ... ...

    Abstract State and local health departments established the California Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Respiratory Virus Sentinel Surveillance System to conduct enhanced surveillance for SARS-CoV-2 and other respiratory pathogens at sentinel outpatient testing sites in 10 counties throughout California, USA. We describe results obtained during May 10, 2020‒June 12, 2021, and compare persons with positive and negative SARS-CoV-2 PCR results by using Poisson regression. We detected SARS-CoV-2 in 1,696 (19.6%) of 8,662 specimens. Among 7,851 specimens tested by respiratory panel, rhinovirus/enterovirus was detected in 906 (11.5%) specimens and other respiratory pathogens in 136 (1.7%) specimens. We also detected 23 co-infections with SARS-CoV-2 and another pathogen. SARS-CoV-2 positivity was associated with male participants, an age of 35-49 years, Latino race/ethnicity, obesity, and work in transportation occupations. Sentinel surveillance can provide useful virologic and epidemiologic data to supplement other disease monitoring activities and might become increasingly useful as routine testing decreases.
    Mesh-Begriff(e) Adult ; COVID-19 ; Coinfection ; Humans ; Male ; Middle Aged ; Polymerase Chain Reaction ; SARS-CoV-2 ; Sentinel Surveillance
    Sprache Englisch
    Erscheinungsdatum 2021-12-06
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, U.S. Gov't, P.H.S. ; Review
    ZDB-ID 1380686-5
    ISSN 1080-6059 ; 1080-6040
    ISSN (online) 1080-6059
    ISSN 1080-6040
    DOI 10.3201/eid2801.211682
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang